Chemotherapy-induced nausea and vomiting: exploring patients’ subjective experience

Figures & data

Figure 1 Interview guidelines.

Abbreviation: CINV, chemotherapy-induced nausea and vomiting.

Table 1 Characteristics of patients (n=13)

Number	Patients’ ID	Age (years)	Marital status	Employment status	Breast cancer stages	Duration since cancer diagnosis (months)	Chemotherapy cycle	Chemotherapeutic agents
1	P 18	44	Married	Sales person	II	10	Third	TAC
2	P 21	48	Divorced	Businesswoman	III	6	Second	FEC
3	P 22	46	Married	Businesswoman	II	24	Third	FEC
4	P 23	51	Married	Retiree	II	6	Third	FEC
5	P 24	47	Married	Housewife	III	16	Fourth	T
6	P 25	42	Married	Housewife	II	6	Third	FEC
7	P 26	47	Married	Public servant	II	3	Fifth	T
8	P 27	66	Divorced	Public servant	II	4	Fourth	FEC
9	P 42	55	Married	Housewife	IV	4	Fourth	T
10	P 43	36	Married	Public servant	III	3	Second	FEC
11	P 47	44	Married	Public servant	III	3	Second	TAC
12	P 48	44	Married	Public servant	II	4	Fourth	FEC
13	P 49	45	Married	Housewife	III	6	Fourth	FEC

Abbreviations: TAC, docetaxel, doxorubicin, and cyclophosphamide; FEC, 5-fluorouracil, epirubicin, cyclophosphamide; T, docetaxel; ID, identification.